Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma von Ansell, Stephen M., Radford, John, Connors, Joseph M., Długosz-Danecka, Monika, Kim, Won-Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Hutchings, Martin, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J.

Volltext

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis von Kim, Seok Jin, Prof, Yoon, Dok Hyun, MD, Jaccard, Arnaud, MD, Chng, Wee Joo, MD, Lim, Soon Thye, MD, Hong, Huangming, MD, Park, Yong, MD, Chang, Kian Meng, MD, Maeda, Yoshinobu, MD, Ishida, Fumihiro, Prof, Shin, Dong-Yeop, MD, Kim, Jin Seok, MD, Jeong, Seong Hyun, MD, Yang, Deok-Hwan, MD, Jo, Jae-Cheol, MD, Lee, Gyeong-Won, MD, Choi, Chul Won, Prof, Lee, Won-Sik, MD, Chen, Tsai-Yun, MD, Kim, Kiyeun, Jung, Sin-Ho, PhD, Murayama, Tohru, MD, Oki, Yasuhiro, MD, Advani, Ranjana, MD, d'Amore, Francesco, Prof, Schmitz, Norbert, Prof, Suh, Cheolwon, Prof, Suzuki, Ritsuro, MD, Kwong, Yok Lam, Prof, Lin, Tong-Yu, MD, Kim, Won Seog, Prof

Volltext

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase... von Song, Yuqin, Malpica, Luis, Cai, Qingqing, Zhao, Weili, Zhou, Keshu, Wu, Jianqiu, Zhang, Huilai, Mehta-Shah, Neha, Ding, Kaiyang, Liu, Yao, Li, Zengjun, Zhang, Liling, Zheng, Meifang, Jin, Jie, Yang, Haiyan, Shuang, Yuerong, Yoon, Dok Hyun, Gao, Sujun, Li, Wenyu, Zhai, Zhimin, Zou, Liqun, Xi, Yaming, Koh, Youngil, Li, Fei, Prince, Miles, Zhou, Hui, Lin, Lie, Liu, Hui, Allen, Pamela, Roncolato, Fernando, Yang, Zhenfan, Kim, Won-Seog, Zhu, Jun

Volltext

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study von Ribrag, Vincent, Kim, Won Seog, Bouabdallah, Reda, Lim, Soon Thye, Coiffier, Bertrand, Illes, Arpad, Lemieux, Bernard, Dyer, Martin J S, Offner, Fritz, Felloussi, Zakia, Kloos, Ioana, Luan, Ying, Vezan, Remus, Graef, Thorsten, Morschhauser, Franck

Volltext

Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (N... von Yamaguchi, Motoko, Suzuki, Ritsuro, Kwong, Yok‐Lam, Kim, Won Seog, Hasegawa, Yuichi, Izutsu, Koji, Suzumiya, Junji, Okamura, Takayuki, Nakamura, Shigeo, Kawa, Keisei, Oshimi, Kazuo

Volltext

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study von LEE, Jeeyun, SUH, Cheolwon, HYO JIN KIM, SOON IL LEE, JUNG HAN KIM, PARK, Jinny, SEOK JOONG OH, KIM, Kihyun, JUNG, Chulwon, PARK, Keunchil, WON SEOG KIM, YEON HEE PARK, KO, Young H, SOO MEE BANG, JAE HOON LEE, DAE HO LEE, HUH, Jooryung, SUNG YONG OH, KWON, Hyuk-Chan

Volltext

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma von Park, Sarah, Lee, Jeeyun, Ko, Young Hyeh, Han, Arum, Jun, Hyun Jung, Lee, Sang Chul, Hwang, In Gyu, Park, Yeon Hee, Ahn, Jin Seok, Jung, Chul Won, Kim, Kihyun, Ahn, Yong Chan, Kang, Won Ki, Park, Keunchil, Kim, Won Seog

Volltext

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea von Ogura, Michinori, Kim, Won-Seog, Uchida, Toshiki, Uike, Naokuni, Suehiro, Youko, Ishizawa, Kenichi, Nagai, Hirokazu, Nagahama, Fumiko, Sonehara, Yusuke, Tobinai, Kensei

Volltext

CD79B and MYD88 mutations in diffuse large B-cell lymphoma von Kim, Yuil, MD, PhD, Ju, Hyunjeong, Kim, Dong Hoon, MD, Yoo, Hae Yong, PhD, Kim, Suk Jin, MD, PhD, Kim, Won Seog, MD, PhD, Ko, Young Hyeh, MD, PhD

Volltext

Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009 von Kwong, Yok-Lam, Prof, Anderson, Benjamin O, Prof, Advani, Ranjana, MD, Kim, Won-Seog, Prof, Levine, Alexandra M, Prof, Lim, Soon-Thye, Dr

Volltext

Treatment of localized extranodal NK/T cell lymphoma, nasal type von Kim, Seok Jin, Kim, Won Seog

Volltext

Aggressive natural killer cell leukemia: Therapeutic potential of l‐asparaginase and allogeneic hematopoietic stem cell transplantation von Ishida, Fumihiro, Ko, Young Hyeh, Kim, Won Seog, Suzumiya, Junji, Isobe, Yasushi, Oshimi, Kazuo, Nakamura, Shigeo, Suzuki, Ritsuro

Volltext

Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy von Yamaguchi, Motoko, Suzuki, Ritsuro, Kim, Seok Jin, Ko, Young Hyeh, Oguchi, Masahiko, Asano, Naoko, Miyazaki, Kana, Terui, Yasuhiko, Kubota, Nobuko, Maeda, Takeshi, Kobayashi, Yukio, Amaki, Jun, Soejima, Toshinori, Saito, Bungo, Shimoda, Emiko, Fukuhara, Noriko, Tsukamoto, Norifumi, Shimada, Kazuyuki, Choi, Ilseung, Utsumi, Takahiko, Ejima, Yasuo, Kim, Won Seog, Katayama, Naoyuki

Volltext

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Sehn, Laurie H, Herrera, Alex F, Flowers, Christopher R, Kamdar, Manali K, McMillan, Andrew, Hertzberg, Mark, Assouline, Sarit, Kim, Tae Min, Kim, Won Seog, Ozcan, Muhit, Hirata, Jamie, Penuel, Elicia, Paulson, Joseph N, Cheng, Ji, Ku, Grace, Matasar, Matthew J

Volltext

A Clamping Force Performance Evaluation of the Electro Mechanical Brake Using PMSM von Baek, Seung-Koo, Oh, Hyuck-Keun, Kim, Seog-Won, Seo, Sung-Il

Volltext

Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma von Kim, Joo Hyun, Kim, Won Seog, Park, Chaehwa

Volltext

A study on the dynamic behavior of the Korean next-generation high-speed train von Jeon, Chang-Sung, Kim, Young-Guk, Park, Joon-Hyuk, Kim, Seog-Won, Park, Tae-Won

Volltext

Lysine demethylase LSD1 is associated with stemness in EBV-positive B cell lymphoma von Kim, Joo Hyun, Park, Chaehwa, Kim, Won Seog

Volltext

Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines von Tan, Daryl, Dr, Tan, Soo Yong, MD, Lim, Soon Thye, MD, Kim, Seok Jin, MD, Kim, Won-Seog, Prof, Advani, Ranjana, Prof, Kwong, Yok-Lam, Prof

Volltext

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma von Vitolo, Umberto, Trněný, Marek, Belada, David, Burke, John M, Carella, Angelo Michele, Chua, Neil, Abrisqueta, Pau, Demeter, Judit, Flinn, Ian, Hong, Xiaonan, Kim, Won Seog, Pinto, Antonio, Shi, Yuan-Kai, Tatsumi, Yoichi, Oestergaard, Mikkel Z, Wenger, Michael, Fingerle-Rowson, Günter, Catalani, Olivier, Nielsen, Tina, Martelli, Maurizio, Sehn, Laurie H

Volltext